New & Notable

GLP-1 real-world weight loss falls short of trial results

GLP-1 real-world weight loss falls short of trial results

GLP-1 drugs like semaglutide and tirzepatide deliver lower weight loss in real-world use than in clinical trials, due to early discontinuation, suboptimal dosing and access challenges.

RFK Jr. names 8 new members to CDC vaccine advisory committee

RFK Jr. names 8 new members to CDC vaccine advisory committee

RFK Jr. appoints eight new members to the CDC Advisory Committee on Immunization Practices, days after firing the panel's 17 sitting members.

How oral GLP-1 drugs could disrupt the weight loss market

How oral GLP-1 drugs could disrupt the weight loss market

FDA-approved oral GLP-1 formulations for weight loss could disrupt the weight management market, outcompete injectables and reduce patient access barriers.

RFK Jr. removes all 17 members of vaccine advisory committee

RFK Jr. removes all 17 members of vaccine advisory committee

HHS Secretary RFK Jr. removes all 17 CDC vaccine advisory panel members, sparking industry concerns over vaccine policy, patient access and public trust.

View All The Latest News

Insights

Insights is research conducted by and for TechTarget Xtelligent Healthcare. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.

Access All Reports

Healthcare Strategies: A Podcast

  • A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.

    Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.

    View All Episodes

Latest News

View All The Latest News

Features

View All Features